Stack of newspapers on a computer keyboard.

In the News

Regulatory Focus (November 2017)

A New Regulatory Paradigm for Medical Devices in India

Vibhu Yadav, Dushyant Kumar and Nancy Mathewson outlines medical device classification rules, manufacturer registration procedures, dossier filing procedures, and pre-clinical and marketing application approval processes.

regulatory focus logo
Regulatory Focus (November 2017)

The Medical Device Coordination Group: A New Authority Under EU Device Regulations

This article by Robert Cumming and Nancy Mathewson discusses the organization and functions of the Medical Device Coordination Group established under the new EU Medical Device Regulation and In Vitro Diagnostic Medical Device Regulation.

regulatory focus logo
Pharmaceutical Outsourcing (November 2017)

Analytical Testing – Extractables and Leachables Testing for Pharmaceutical Products

Xiaochun Yu and Derek Wood provide a detailed overview of extractables and leachables.

pharmaceutical outsourcing logo
Applied Clinical Trials (November 2017)

The Virtual Opportunity in Rare Disease Trials

In this article written by Karen Kaucic, Horacio Plotkin and Christopher Komelasky, the authors discuss how rare disease research can be solved with virtual trials and their supporting technologies.

applied clinical trials logo
Regulatory Rapporteur (November 2017)

Marketing applications for biopharmaceuticals: Considerations for different jurisdictions – Part 2

In this two-part series, John Watkins and Clare Ryder highlight the similarities and differences in global submission requirements.

regulatory rapporteur logo
PharmaVOICE (November 2017)

2017 year in preview: Trends revisited

Jai Balkissoon, M.D., and Elizabeth Madichie offer their thoughts one year later on the Cancer Moonshot and combination therapies, two of the key trends PharmaVOICE identified for 2017.

PharmaVoice logo
PharmaVOICE (November 2017)

Trending 2018: What does the future hold?

Susan Atkinson comments on risk-based monitoring in this feature in which industry experts identify the trends they think will impact life sciences in the coming year.

PharmaVoice logo
Genetic Engineering and Biotechnology News (October 2017)

Bending the Cost and Time Curve of Drug Development through the Use of Biomarkers

In this article written by Katie Matys and Janine McKnight, the authors discuss how the right biomarker can make all the difference in a drug-development program.

GEN logo
Regulatory Rapporteur (October 2017)

Marketing applications for biopharmaceuticals: Considerations for different jurisdictions – Part 1

In this two-part series, John Watkins and Clare Ryder highlight the similarities and differences in global submission requirements.

regulatory rapporteur logo